Following these reports, we also observed that administration of a PPARγ antagonist to HFD-fed mice diminished HFD-induced obesity and fatty liver disease while being associated with the restoration of eNOS expression in adipocytes. The gene discussed is NOS3; the disease is fatty liver disease.